Kategori: Uncategorized

Nordic Capital investerar tillsammans med Astorg i Cytel, ett företag verksamt inom utformning av kliniska studier åt läkemedelsföretag

Cytel is one of the leading global providers of clinical trial design technology, biometric services and advanced analytics, focusing on optimizing clinical trials and helping pharmaceutical companies to unlock the full potential of their clinical and real-world data  Nordic Capital and Astorg will actively support and accelerate Cytel’s next phase of growth and innovation, drawing on their extensive experience of investing in healthcare and technology Read more

21 december 2020

Nordic Capital Fund X förvärvar RegTech

Nordic Capital has signed an agreement with management and technology consulting firm BearingPoint to acquire BearingPoint RegTech (“RegTech” or the “Company”), a leading European provider of unique software solutions across the regulatory value chain. Nordic Capital intends to support RegTech’s next phase of innovation and sustainable growth by investing in the Company’s continued product development, enhancing its organisational capacity and expanding its international footprint. Read more

4 november 2020

NAXS Delårsrapport januari–september 2020

Nio månader 2020 Resultat efter skatt uppgick till -6,0 (26,4) MSEK. Resultatet per aktie uppgick till -0,54 (2,29) SEK. Substansvärdet uppgick till 676 MSEK (60,58 SEK per aktie) per den 30 september 2020, jämfört med 710 MSEK (SEK 63,63 per aktie) per den 31 december 2019. Nettokassan uppgick till 215 MSEK (19,29 SEK per aktie) […] Read more

20 oktober 2020

Nordic Capital har investerat i Siteimproved

Siteimprove is a global leader within website experience and digital marketing optimisation, offering a comprehensive platform on a strong growth trajectory. Nordic Capital will support the Company’s future growth journey as the new majority owner in close partnership with the CEO & Founder. Read more

3 september 2020

NAXS Halvårsrapport januari – juni 2020

Första halvåret 2020 Resultat efter skatt uppgick till -61,0 (14,7) MSEK. Resultatet per aktie uppgick till -5,47 (1,25) SEK.  Substansvärdet uppgick till 618 MSEK (55,42 SEK per aktie) per den 30 juni 2020, jämfört med 710 MSEK (SEK 63,63 per aktie) per den 31 december 2019. Nettokassan uppgick till 207 MSEK (18,60 SEK per aktie) […] Read more

14 juli 2020